Yasin Bhanji

Mar 13, 2024 | onlinelibrary.wiley.com | Sean Fletcher |Mufaddal Mamawala |Albert E. Holler |Yasin Bhanji

To validate the use of a cumulative cancer locations (CCLO) score, a measurement of tumor volume on biopsy, and to develop a novel magnetic resonance imaging (MRI)-informed CCLO (mCCLO) score to predict clinical outcomes on active surveillance (AS). The CCLO score is a sum of uniquely involved sextants with prostate cancer on diagnostic + confirmatory biopsy. The mCCLO score incorporates MRI findings into the CCLO score.